Advertisement
Advertisement

Read Now: HIV 2014 Year in Review >>

Prevention/Epidemiology

NEJM PMTCT Studies

October 15, 2010

Two studies published in the New England Journal of Medicine "equip us with strategies to deal with the current imperfections in our scale-up efforts" to prevent mother-to-child transmission of HIV, write Marc Lallemant and Gonzague Jourdain of the Harvard School of Public Health in a New England Journal of Medicine editorial. The editorial compares the findings with updated WHO guidelines on PMTCT. The editorial also looks at questions that arise given the findings including: the difference in long-term response to the two drugs, strategies for preserving or "recycling" nevirapine therapy and the higher cost of ritonavir-boosted lopinavir compared with nevirapine (10/14).

Back to other news for October 2010


This information was reprinted from kff.org with permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives, and sign up for email delivery. © Henry J. Kaiser Family Foundation. All rights reserved.




This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily Global Health Policy Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.
 
See Also
Study Findings on Nevirapine Support WHO HIV Treatment Guideline Changes

No comments have been made.
 

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)

Your Name:


Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:

Advertisement